
In Hepatitis B Vaccine Debate, CDC Panel Sidesteps Key Exposure Risk
The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children. This comes despite a failed attempt to do so at the most recent meeting of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices. Both President Donald Trump and some…